Multiple studies have confirmed that SNHG7 is significantly overexpressed in thyroid cancer tissues and cell lines (13–17), with its upregulation closely associated with increased tumor diameter, TNM staging, and poor patient prognosis (14, 15). This evidence concerns the gene SNHG7 and neoplasm.